HOME >> MEDICINE >> NEWS
Rheumatoid arthritis patients at higher risk for unrecognized heart disease and cardiac sudden death

ROCHESTER, Minn. -- People with rheumatoid arthritis not only have a higher risk of coronary heart disease than those in the general population, but they have more silent, unrecognized heart attacks and sudden cardiac deaths, according to a Mayo Clinic study published in the February issue of Arthritis & Rheumatism (http://www.rheumatology.org/publications/ar). They are also much less likely to complain of chest pain.

The increased heart disease risk may be present even before the diagnosis of rheumatoid arthritis, according to the researchers. During the two years before diagnosis of rheumatoid arthritis, patients with this disease were three times more likely to have been hospitalized for an acute heart attack and five times more likely to have an unrecognized heart attack. They were also less likely to have had a history of chest pain, compared to those without rheumatoid arthritis. After their diagnosis, the rheumatoid arthritis patients were twice as likely to experience unrecognized heart attacks and sudden cardiac deaths.

Hilal Maradit Kremers, M.D., lead study investigator and research associate in the Mayo Clinic Department of Health Sciences Research, says the study suggests three major messages for rheumatoid arthritis patients:

  • The risk of heart attack is already there at the time a rheumatoid arthritis diagnosis is first made.

  • Heart disease can remain silent in those with rheumatoid arthritis. Regular cardiac checkups are important, as is lowering traditional cardiac risk factors, such as taking care of blood pressure and cholesterol and quitting smoking.

  • Heart disease in rheumatoid arthritis patients can manifest for the first time as a cardiac sudden death.

The researchers were surprised to find that the increased cardiac events in rheumatoid arthritis patients could not be explained by an increase in tradition
'"/>

Contact: Lisa Lucier
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
3-Feb-2005


Page: 1 2 3

Related medicine news :

1. Rheumatoid arthritis patients have double the risk of heart failure
2. Rheumatoid arthritis linked to excess risk of congestive heart failure
3. Rheumatoid arthritis patients caught in middle of doctors disagreement over hand surgery
4. Rheumatoid arthritis causes increased complications and health care costs in inpatient and outpatient settings
5. ENBREL (Etanercept) Receives FDA Approval For Treatment Of Juvenile Rheumatoid Arthritis
6. Positive Results Of Pivotal Phase III Trial With ENBREL In Patients With Early, Active Rheumatoid Arthritis
7. Hopkins Researchers Develop New Therapy For Autoimmune Disorders Such As Rheumatoid Arthritis And Lupus
8. Changing Drug Delivery For Rheumatoid Arthritis Patients Increases Effectiveness, Lowers Costs
9. Immunosuppressive Treatment Is Important For Sufferers Of Rheumatoid Arthritis
10. University seeks recruits for arthritis study
11. A shallow hip socket predicts osteoarthritis of the hip

Post Your Comments:
(Date:4/23/2014)... State University researcher is looking to give exercise enthusiasts ... her latest research shows that a cyber buddy can ... Games for Health Journal , is the first to ... better motivator during exercise, a software-generated partner also can ... that isn,t real can still motivate people to give ...
(Date:4/23/2014)... University researchers have identified an important enzyme pathway that ... too few chromosomes, a condition that has been directly ... associate professor of biochemistry, found that near the end ... enzyme that ensures any breaks in DNA are fully ... genome to daughter cells. This process helps safeguard against ...
(Date:4/23/2014)... could help doctors predict which patients might suffer potentially ... The program, which assesses brain scans using pattern recognition ... passport control, has been developed by researchers at Imperial ... the Wellcome Trust, which used the software are published ... Stroke affects over 15 million people each year worldwide. ...
(Date:4/23/2014)... displayed in the popular Swedish children,s TV show ... foods. A new study from the University of ... TV programmes as well as the link between ... status. , Steingerdur Olafsdottir,s doctoral thesis focuses on ... children,s TV show Bolibompa. Healthy foods dominated in ...
(Date:4/23/2014)... about an increase in adolescents, marijuana use following the ... relief. According to a new study at Rhode Island ... states with and without medical marijuana laws, legalizing the ... The study is published online in advance of print ... , "Any time a state considers legalizing medical marijuana, ...
Breaking Medicine News(10 mins):Health News:Cyber buddy is better than 'no buddy' 2Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2Health News:Airport security-style technology could help doctors decide on stroke treatment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 3Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... FRANKLIN, Ohio , Jan. 15, 2014  A novel wearable ... it easy and painless for patients to self-inject prescription drugs ... of disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... expected to grow to $220B by 2018, according to analysts.   ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
Cached News: